GlassScriptPhysician profile
Pearl Dua
NPI 1902837677
$1,567.90
in general payments reported to CMS, 2019-2025
14 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.58 · 2022: $1,262 · 2023: $94.34 · 2024: $36.67 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $955.85 | 2022 | |
| Si-Bone, INC. | $162.64 | 2022 | |
| Abbott Laboratories | $127.47 | 2022 | |
| Medtronic, INC. | $51.82 | 2025 | Synchromedii |
| Pinnacle, INC | $50.40 | 2025 | |
| Nevro Corp. | $34.79 | 2023 | Senza |
| Abbvie INC. | $33.23 | 2023 | |
| Treace Medical Concepts, INC. | $28.38 | 2025 | |
| Zimmer Biomet Holdings, INC. | $26.32 | 2023 | Avenir, Persona |
| Alexion Pharmaceuticals, INC. | $26.20 | 2025 | Strensiq |
| Stryker Corporation | $22.64 | 2024 | Gamma, T2 Alpha |
| Boston Scientific Corporation | $18.58 | 2021 | |
| Radius Health, INC. | $15.55 | 2022 | |
| Depuy Synthes Sales INC. | $14.03 | 2024 | Monovisc, Orthovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pearl Dua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.